AKT1 and neoplasm: We also found that the xenografted HepG2-S-R tumor growth in nude mice was remarkably inhibited by systemic delivery of MK-2206 (Fig. S3I), thus supporting the important role of AKT/PI3K signaling in glucose metabolism regulation in HCC cells resistant to sorafenib.